دورية أكاديمية
Doxorubicin-Loaded Core-Shell UiO-66@SiO 2 Metal-Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment.
العنوان: | Doxorubicin-Loaded Core-Shell UiO-66@SiO |
---|---|
المؤلفون: | Trushina DB; Federal Research Center Crystallography and Photonics, Russian Academy of Sciences, 119991 Moscow, Russia.; Department of Biomedical Engineering, Sechenov First State Medical University, 119991 Moscow, Russia., Sapach AY; Department of Biomedical Engineering, Sechenov First State Medical University, 119991 Moscow, Russia.; Center for Neurobiology and Brain Restoration (CNBR), Skolkovo Institute of Science and Technology, 143025 Moscow, Russia., Burachevskaia OA; The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia., Medvedev PV; The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia., Khmelenin DN; Federal Research Center Crystallography and Photonics, Russian Academy of Sciences, 119991 Moscow, Russia., Borodina TN; Federal Research Center Crystallography and Photonics, Russian Academy of Sciences, 119991 Moscow, Russia., Soldatov MA; The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia., Butova VV; The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia. |
المصدر: | Pharmaceutics [Pharmaceutics] 2022 Jun 23; Vol. 14 (7). Date of Electronic Publication: 2022 Jun 23. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI |
مستخلص: | Beneficial features of biocompatible high-capacity UiO-66 nanoparticles, mesoporous SiO |
References: | Mol Pharm. 2009 Mar-Apr;6(2):407-15. (PMID: 19718794) Front Immunol. 2020 Mar 04;11:218. (PMID: 32194546) J Am Chem Soc. 2008 Nov 5;130(44):14358-9. (PMID: 18844356) J Am Chem Soc. 2014 Apr 9;136(14):5181-4. (PMID: 24669930) ACS Appl Mater Interfaces. 2021 May 5;13(17):19701-19709. (PMID: 33900738) J Am Chem Soc. 2008 Oct 22;130(42):13850-1. (PMID: 18817383) ACS Appl Mater Interfaces. 2020 Sep 2;12(35):38989-39004. (PMID: 32805901) Chemistry. 2015 Feb 2;21(6):2508-18. (PMID: 25504892) J Control Release. 2008 Sep 10;130(2):98-106. (PMID: 18534704) J Mater Chem B. 2020 Jul 28;8(28):6128-6138. (PMID: 32568335) Nanotechnology. 2021 May 12;32(29):. (PMID: 33853047) Acc Chem Res. 2008 Jan;41(1):120-9. (PMID: 17655275) Adv Mater. 2012 Dec 18;24(48):6433-7. (PMID: 23001882) Inorg Chem. 2021 Apr 19;60(8):5694-5703. (PMID: 33830750) Biomaterials. 2015 Aug;61:266-78. (PMID: 26005765) Langmuir. 2017 May 30;33(21):5253-5260. (PMID: 28489388) J Am Chem Soc. 2008 Sep 3;130(35):11584-5. (PMID: 18686947) Sci Rep. 2014 Nov 14;4:7053. (PMID: 25394493) Drug Discov Today. 2017 Feb;22(2):270-281. (PMID: 27890669) Mikrochim Acta. 2019 Feb 20;186(3):196. (PMID: 30788595) Nature. 2013 Aug 22;500(7463):486-9. (PMID: 23851396) Chem Sci. 2016 Aug 1;7(8):5294-5301. (PMID: 30155180) Chem Soc Rev. 2021 May 7;50(9):5397-5434. (PMID: 33666625) Nanomaterials (Basel). 2018 Oct 23;8(11):. (PMID: 30360511) Chem Commun (Camb). 2012 Sep 28;48(75):9388-90. (PMID: 22892418) Langmuir. 2011 Aug 2;27(15):9535-40. (PMID: 21732647) J Am Chem Soc. 2009 Oct 14;131(40):14261-3. (PMID: 19807179) Acc Chem Res. 2011 Oct 18;44(10):957-68. (PMID: 21648429) Chem. 2017 Apr 13;2(4):561-578. (PMID: 28516168) Nanoscale. 2018 Mar 29;10(13):6205-6211. (PMID: 29560986) Int J Mol Sci. 2021 Jan 14;22(2):. (PMID: 33466760) Chem Soc Rev. 2015 Oct 7;44(17):6287-305. (PMID: 26056687) J Colloid Interface Sci. 2013 Feb 15;392:288-296. (PMID: 23137909) J Am Chem Soc. 2008 Jul 23;130(29):9216-7. (PMID: 18576625) J Am Chem Soc. 2014 Dec 3;136(48):16712-5. (PMID: 25407895) J Am Chem Soc. 2014 May 14;136(19):6786-9. (PMID: 24786337) Chem Commun (Camb). 2014 Aug 14;50(63):8779-82. (PMID: 24967656) |
معلومات مُعتمدة: | 19-73-10069 Russian Science Foundation; 21-74-10058 Russian Science Foundation |
فهرسة مساهمة: | Keywords: MOF; UiO-66; chemotherapy; doxorubicin; folate receptors; nano-MOF; nanoparticles; silanization; silica shell; tumor targeting |
تواريخ الأحداث: | Date Created: 20220727 Latest Revision: 20220731 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC9324125 |
DOI: | 10.3390/pharmaceutics14071325 |
PMID: | 35890221 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1999-4923 |
---|---|
DOI: | 10.3390/pharmaceutics14071325 |